Illuminating the Headlines
Food and Drug Administration approved an mRNA-based vaccine for influenza. Live Science asked experts what that means for the future of mRNA vaccines in the U.S.
Invasive fungal infections are notoriously hard to catch early, and even harder to rule out with confidence. At the Parasitology-Mycology Laboratory of CHU Bordeaux, Consultant Physician Dr Frédéric Gabriel has spent years refining how his lab uses β-D-glucan (BDG) testing to sharpen that judgement call – including with the Wako β-glucan test. In this interview, he explains what the guidelines say, what actually happens at the bench, and where he sees the test heading next.
The conventional wisdom about opting for lower-fat dairy may not be the best health advice after all, a new study finds.
Severe COVID-19 may reactivate some dormant viruses that remain in the body after previous infections, a new study suggests.
UNC researchers are recruiting North Carolinians for a national trial studying whether a blood test could help detect multiple cancers earlier.
For most healthy people, Cryptococcus is an unnoticed infection. The immune system walls it off in the lungs and keeps it dormant for life. But in patients undergoing cancer chemotherapy, recovering from an organ transplant, living with HIV or taking newer immunosuppressing drugs for autoimmune disease, the fungus can reactivate, spread to the brain and cause meningitis.
A Vanderbilt Health and TGen team applied spatial transcriptomics to heart transplant biopsies, uncovering cellular programs linked to rejection, therapy response, and cardiac allograft vasculopathy.
Responding to this shift, OneHealth by AXA continues to strengthen access to preventive, diagnostic and specialist medical services through…
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that while traditional pathological features used to classify aggressive prostate cancer—such as high-grade disease, cancer extending outside the prostate and cancer involving the seminal vesicles—after surgery can help identify patients who are more likely to have worse outcomes, they do not predict who will benefit more from adding hormone therapy to postoperative radiation.
Researchers at the University of Colorado Anschutz Cancer Center have identified a previously unknown metabolic weakness in the stem cells that drive high-risk myelodysplastic syndromes (MDS), a discovery that could lead to more targeted treatments for this aggressive blood cancer.
Headlines refresh automatically every 5 minutes. All articles link to their original sources.